Hyperbaric oxygen is marketed almost everywhere for almost everything — autism, MS, cerebral palsy, rheumatoid arthritis, cancer, “detox.” We hold a different line. This page is an honest account of the conditions Evolve does not treat with HBOT, and the evidence behind that decision.
Conditions · Evidence & Ethics
Off-Label Conditions We Choose Not to Treat
- We decline what the evidence doesn’t support
- Evidence-first, marketing-never
Where We Draw the Line
The standard a condition has to meet
Evolve does offer a small number of off-label, private-pay indications — but only ones that clear a real bar. We think it’s just as important to be clear about what we won’t offer, no matter how much it’s requested or how well it might sell.
We will consider an off-label use only when all of these are true
- There is a plausible biological mechanism for benefit.
- There is a genuine, emerging evidence base — not just testimonials.
- It is delivered with physician consultation and honest informed consent, including a frank discussion of how limited the evidence is.
- The potential benefit reasonably outweighs the real risks of pressurized oxygen.
The conditions below don’t meet that standard. For most, the evidence is absent, weak, or actively negative. For some, hyperbaric oxygen is simply not a treatment for the condition at all. In every case, our answer is the same: we don’t offer it.
Why we’re this careful. Hyperbaric oxygen is not risk-free. It can cause ear and sinus barotrauma, temporary changes in vision, and — rarely — oxygen-toxicity seizures. Controlled trials in children have reported more adverse events with HBOT than with sham. Exposing a patient to those risks, and often a large out-of-pocket cost, for an unproven benefit is not something we’re willing to do.
Neurodevelopmental & pediatric conditions Evidence does not support
These are the conditions where marketing most often targets hopeful families — and where we feel the strongest duty to be straight with parents. We say this with real respect for how hard these journeys are.
| Condition | Why we don’t offer it |
|---|---|
| Autism spectrum disorder | Controlled trials and systematic reviews do not show that HBOT improves core symptoms. The one positive trial has not been replicated, and reviews conclude the evidence does not support its use. We do not offer it. |
| Cerebral palsy | A systematic review of randomized trials found HBOT no better than pressurized air for motor or cognitive function — and found more adverse events in children who received it. This is high-level evidence against routine use. |
Neurological & neurodegenerative conditions Insufficient or absent evidence
These are the conditions where marketing most often targets hopeful families — and where we feel the strongest duty to be straight with parents. We say this with real respect for how hard these journeys are.
| Condition | Why we don’t offer it |
|---|---|
| Multiple sclerosis | Studied in controlled trials since the 1980s; the accumulated evidence does not show consistent benefit, and major reviews do not recommend HBOT for MS. |
| Myasthenia gravis | An autoimmune neuromuscular disease managed with established immunotherapies. There is no evidence base supporting hyperbaric oxygen as a treatment, and it is not an accepted indication. Not offered. |
| Parkinson’s disease | No adequate controlled evidence of benefit. Not an established indication. |
| Spinal cord injury (chronic) | Evidence does not support HBOT as a treatment for established spinal cord injury. |
| Bell’s palsy · chronic tinnitus | Marketed in places, but without a controlled evidence base sufficient to justify treatment. (Note: sudden sensorineural hearing loss within the therapeutic window is a recognized indication we treat — chronic tinnitus is not.) |
Mental-health conditions Insufficient evidence
| Condition | Why we don’t offer it |
|---|---|
| Depression · anxiety | Research is early and inconclusive; HBOT is not an established treatment for these conditions. Effective, evidence-based care exists, and patients are best served by it rather than by an unproven and costly alternative. |
Cosmetic & lifestyle uses Not a medical indication
| Use | Why we don’t offer it |
|---|---|
| Cosmetic skin rejuvenation · “oxygen facials” | Not an evidence-based use of hyperbaric oxygen. (Distinct from filler-induced vascular occlusion, a genuine complication we do treat.) |
| Jet lag · general fatigue | No medical indication. Not offered. |
Cancer & systemic-disease claims HBOT is not a treatment for these
| Claim | Why we don’t offer it |
|---|---|
| Cancer (as a cancer therapy) | Hyperbaric oxygen is not a treatment for cancer and does not cure it. The only cancer-related indication is delayed radiation injury — repairing healthy tissue damaged by past radiation — which we do treat. We do not offer HBOT as an anti-cancer therapy or a substitute for oncology care. |
| Diabetes (as a cure) | HBOT does not treat or cure diabetes. It is used for specific diabetic complications — chronic non-healing diabetic wounds — which we treat. The disease itself is not a hyperbaric indication. |
| Chronic Lyme disease · HIV/AIDS · autoimmune disease (general) | No credible evidence supports HBOT for these conditions. Not offered. |
| Heart disease · general “circulation” claims | HBOT is not a treatment for coronary or cardiovascular disease. Not offered. |
Chronic pain, rheumatologic & other marketed uses Insufficient evidence
| Condition | Why we don’t offer it |
|---|---|
| Rheumatoid arthritis | An autoimmune joint disease managed with established disease-modifying and anti-inflammatory therapy. HBOT is not an evidence-based treatment for rheumatoid arthritis and is not an accepted indication. Not offered. |
| Osteoarthritis (general) | Not an established hyperbaric indication. |
| Macular degeneration & general eye conditions | Not an evidence-based use. (Central retinal artery occlusion is an acute emergency handled in hospital — see our emergency indications page.) |
| Allergies · asthma | No medical basis for hyperbaric treatment. Not offered. |
This list is representative, not exhaustive. If a condition isn’t named here and isn’t on our conditions we treat or off-label pages, the safe assumption is that we don’t offer HBOT for it — and you’re welcome to ask.
The Difference That Matters
Offering hope isn't the same as offering evidence
What we will do
Offer a carefully chosen off-label indication when there’s a plausible mechanism and real emerging evidence — with a physician consultation, written informed consent, and an honest conversation about how strong (or weak) the evidence actually is.
Common Questions
Questions families and patients ask
I've read that hyperbaric oxygen helped a child with autism. Why won't you offer it?
We understand why families explore every option, and we don’t dismiss anyone’s hope. But the controlled research — the kind that can separate real effect from wishful thinking — does not show that HBOT improves autism, and trials in children have found more side effects than benefit. Offering an unproven, costly treatment with real risks isn’t something we can do in good conscience. We’re always glad to talk it through honestly.
Another clinic offers HBOT for MS, rheumatoid arthritis, and "detox." Are they wrong?
We can’t speak for other clinics, only for our own standard. For those uses, the evidence does not meet the bar we hold before we’ll treat someone. We’d rather lose the booking than provide a treatment we don’t believe the evidence supports.
Can hyperbaric oxygen treat cancer?
No. HBOT is not a cancer treatment and does not cure cancer. The only cancer-related use is treating delayed radiation injury — damage to healthy tissue from prior radiation therapy — which we do offer. Anyone offering hyperbaric oxygen as a cancer cure is not being straight with you.
What if new evidence changes?
We review our positions as the science evolves. If strong evidence emerges for a use we currently decline, we’ll revisit it — with the same standard of mechanism, evidence, consent, and honest risk–benefit that we apply to everything.
References & Sources
Selected sources
- Xiong T, Chen H, Luo R, et al. Hyperbaric oxygen therapy for people with autism spectrum disorder (ASD). Cochrane Database Syst Rev. 2016.
- Lacey DJ, et al. Hyperbaric oxygen in children with cerebral palsy: a systematic review of effectiveness and safety. (Finds no motor/cognitive benefit; higher adverse-event rate in children.) PMC9565562.
- Bennett MH, et al. Hyperbaric oxygen therapy for multiple sclerosis. Cochrane Database Syst Rev. (No consistent evidence of benefit; not recommended for routine use.)
- Undersea & Hyperbaric Medical Society. Hyperbaric Oxygen Therapy Indications — approved indications list. uhms.org
- U.S. Food & Drug Administration. Hyperbaric Oxygen Therapy: Don’t Be Misled — consumer safety communication on unproven HBOT marketing. fda.gov
This page is for general education and does not replace individual medical assessment. Evidence summaries reflect the state of the literature at the time of last review.
Medical review
Dr. Vik Agarwal MD CCFP FRCPC CAQ-HP — President, Evolve Medical Group
Dr. Seema Agarwal MD CCFP CAQ-HP — Chief Medical Officer, Evolve Hyperbarics
Last reviewed: May 2026 · Next: May 2027
Urgent Referral
Have a condition you're wondering about?
We’ll give you an honest answer — including when that answer is “the evidence isn’t there, and
here’s why.” Call a care coordinator or start with an eligibility check.
Medical disclaimer. This page provides general, educational information about the scope of hyperbaric services at Evolve Hyperbarics and about the evidence for various uses of hyperbaric oxygen therapy. It is not medical advice and does not establish a physician–patient relationship. Individual decisions should be made in consultation with a qualified physician.